NCT06646614 Group Advanced Care Planning Pilot for Veterans
| NCT ID | NCT06646614 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Palo Alto Health Care System |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-07-15 |
| Primary Completion | 2027-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-07-15 with a primary completion date of 2027-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The proposed research aims to engage participants in group educational sessions to facilitate learning of topics related to advanced care planning and to determine whether this approach is more effective than usual care alone.
Eligibility Criteria
Inclusion Criteria: 1. All patients \>18 years old with newly diagnosed cancer are eligible. 2. Patients must have the ability to understand and willingness to provide verbal consent 3. Participants must speak English Exclusion Criteria: 1. Inability to consent to the study 2. Plans to move within the area and leave the VA system within 4 months
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06646614 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06646614 currently recruiting?
Yes, NCT06646614 is actively recruiting participants. Contact the research team at manalip@stanford.edu for enrollment information.
Where is the NCT06646614 trial being conducted?
This trial is being conducted at Palo Alto, United States.
Who is sponsoring the NCT06646614 clinical trial?
NCT06646614 is sponsored by VA Palo Alto Health Care System. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.